Elevance Health, Inc. (ELV) Options Risk Score
Real-time risk analysis for ELV options traders — updated every 30 minutes.
Data last updated: 2026-07-23
Run a full ELV options risk analysis
See the complete risk breakdown — news catalysts, SEC filings, legal proceedings, earnings overlap, IV vs HV, options flow and Expected Move — all in one scan.
Scan ELV Now — Free →
Is it risky to sell options on Elevance Health, Inc. (ELV) right now?
For a 4-week expiry, Elevance Health, Inc. (ELV) carries an options catalyst-risk score of 100 out of 100 (HIGH). The contributing signals are 14 recent news items, 10 active legal filings and 2 clinical-trial catalysts within the 4-week window. Anything at 70 or above counts as HIGH, meaning the premium on ELV is at least partly compensation for a scheduled event rather than pure time value. It says nothing about direction — only that something is on the calendar.
ELV shows an IV Rank of 19, near the low end of its one-year range — options are relatively cheap, which favours option buyers over sellers, with a current implied volatility of about 35%. IV Rank answers how ELV options are priced against their own history, which is the starting point for choosing between selling and buying premium.
ELV does not report again until 2026-07-15, so near-dated expiries avoid it.
TickerRisk provides risk scoring for informational purposes only. This is not financial advice. Options trading involves substantial risk of loss. Full disclaimer